Where is ClotPro located?

ClotPro is headquartered in Munich, Germany.

Is ClotPro a funded company?

ClotPro is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does ClotPro rank among its competitors?

ClotPro ranks 13th amongst 30 active competitors, of which 8 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was MedicQuant ApS, which secured $81.9K in Jul, 2023.

Who are the top competitors of ClotPro?

ClotPro's top competitors include Diagnostica Stago, Coag-Sense and Accriva Diagnostics. Among them, MedicQuant ApS secured the most recent funding round in July, 2023.

ClotPro - 2026 Company Profile, Team & Competitors

ClotPro is an acquired company based in Munich (Germany), founded in 2017 by Andreas Calatzis. It operates as a Provider of device for coagulation diagnostic. The company has 30 active competitors, including 8 funded and 5 that have exited. Its top competitors include companies like Diagnostica Stago, Coag-Sense and Accriva Diagnostics.

Company Details

ClotPro is a diagnostic instrument for the functional analysis of blood coagulation using Elastic Motion Thrombelastography (EMT). Tip technology is designed for reagent handling on the ClotPro analyzer. The reagents are present in a little sponge in the pipetting tip in dry form. During pipetting of the blood sample the reagents are transferred into the blood.

Website: clot.pro
Email ID: *****@clot.pro
Phone Number: +49 **********

Key Metrics

Founded Year

2017

Location

Munich, Germany

Stage

Acquired

Ranked

13^th among 30 active competitors

Similar Companies

Diagnostica Stago & 32 more

Exit Details

Acquired by Haemonetics (Apr 02, 2020)

View ClotPro's full profile

ClotPro got acquired by Haemonetics on Apr 02, 2020.

Click here to take a look at ClotPro's acquisition in detail

ClotPro has not raised any funding rounds yet.

The founders of ClotPro is Andreas Calatzis.

Here are the details of ClotPro's key team members:

Andreas Calatzis: CEO, founder of ClotPro.

View details of ClotPro's Founder profiles and Board Members

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of ClotPro include Diagnostica Stago, Coag-Sense and Accriva Diagnostics. Here is the list of Top 10 competitors of ClotPro, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Diagnostica Stago 1998, Paris (France), Acquired	Portfolio of products for hematology and hemostasis	-	-	52/100
2nd	Coag-Sense 2008, San Francisco (United States), Series A	Innovating coagulation monitoring with accurate, accessible PT/INR testing solutions	$5M	DSC Investment, Korea Investment Holdings ... & 1 others	49/100
3rd	Accriva Diagnostics 2009, San Diego (United States), Acquired	Develop products/systems for diagnostics.	$144M	Bay City Capital, Kleiner Perkins & 3 others	47/100
4th	Entegrion 2002, Durham (United States), Series B	Provider of hemostasis and fluid replacement products	$30.5M	Sway Ventures, Defense.gov & 4 others	43/100
5th	Enzyre 2016, Nijmegen (Netherlands), Series A	Developer of smart diagnostics devices for blood coagulation analysis	$11.9M	Oost NL, Novalis Biotech & 3 others	40/100
6th	Medical Ingenuities 2011, Wheaton (United States), Series A	Developer of radial artery occlusion devices for hematology treatments	$997K	cultivate(MD), Genesis & 3 others	35/100
7th	Perosphere 2011, Mount Kisco (United States), Acquired	Anticoagulant reversal agent and small molecules to prevent allergic reactions, traumatic brain injury.	$9.36M	Connecticut Innovations	34/100
8th	MedicQuant ApS 2019, Aarhus (Denmark), Seed	Provider of diagnostic kit for blood anticoagulants	-	Waarst Holding, BioInnovation Institute & 2 others	34/100
9th	16•12 2005, Pordenone (Italy), Seed	Provider of a diagnostic device to evaluate the patient's hemorrhagic and thrombotic potential	$900K	Italian Angels for Growth, Europa	33/100
10th	Microvisk 2004, Saint Asaph (United Kingdom), Series B	Provider of a handheld device to monitor blood clots	$16.6M	Finance Wales, Origin Capital & 8 others	32/100
13th	ClotPro 2017, Munich (Germany), Acquired	Provider of device for coagulation diagnostic	-	-	28/100